Hogan Lovells advised Mind Medicine Inc. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), completed its underwritten public offering of 9,285,511 common shares, without value, at an offering...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised Mind Medicine on the deal. Clinical stage biopharmaceutical company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), completed its underwritten offering of 16,666,667 common shares,...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised Perspective Therapeutics on a series of strategic transactions. Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX) has completed a series of strategic transactions with Lantheus Holdings (NASDAQ:...
You must be a Standard 1 Year member to access this content.
Hogan Lovells has advised EyePoint Pharmaceuticals, Inc. on the deal. Cowen and Guggenheim Securities acted as joint book-running managers for the offering. Among other uses, this...
You must be a Standard 1 Year member to access this content.
